
Acute myelogenous leukemia - Symptoms and causes - Mayo Clinic
Dec 20, 2024 · Acute myelogenous leukemia, also called AML, is a cancer of the blood and bone marrow. Bone marrow is the soft matter inside bones where blood cells are made. The word …
Acute myeloid leukemia - Wikipedia
Between 2017 and 2025, 12 new agents have been approved for AML in the U.S., including venetoclax (BCL2 inhibitor), gemtuzumab ozogamicin (CD33 antibody-drug conjugate), and …
Acute Myeloid Leukemia (AML): Symptoms, Treatment & Prognosis
Mar 21, 2023 · What is acute myeloid leukemia (AML)? Acute myeloid leukemia (AML) is a rare cancer that affects your bone marrow and blood. It typically happens when certain genes or …
What Is Acute Myeloid Leukemia (AML)? - American Cancer Society
Acute myeloid leukemia (AML) starts in the bone marrow, the soft inner part of certain bones, where new blood cells are made. Most often AML quickly moves from the bone marrow into …
Acute Myeloid Leukemia Treatment - NCI - National Cancer …
May 16, 2025 · Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. AML is a cancer of the blood and bone …
Acute Myeloid Leukemia - Leukemia Research Foundation
Acute myeloid leukemia (AML) is a blood cancer that starts in the blood and bone marrow and can progress rapidly. Treatment in many cases can lead to a long-term reduction in symptoms …
Acute Myeloid Leukemia (AML) - Dana-Farber Cancer Institute
What Is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a blood and bone marrow cancer in which the bone marrow makes immature white blood cells called myeloblasts or …
Acute Myeloid Leukemia (AML) - MD Anderson Cancer Center
Acute myeloid leukemia is a type of cancer that affects myeloid stem cells, which produce red blood cells, platelets and granulocytes, a type of white blood cell. Learn about the causes, …
Acute Myeloid Leukemia Survival Rates and Outlook
Jun 30, 2025 · Acute myeloid leukemia survival rates and outlook vary greatly and are affected by age, AML type, and response to treatment.
Acute Myeloid Leukemia Treatment (PDQ®) - NCI
Mar 14, 2025 · AML is a heterogenous group of blood cancers that result from clonal expansion of myeloid hematopoietic precursors in the bone marrow.